- You are here: Home |
- CML Generics |
- What´s in the news? |
- June 24, 2015: Class Action Alleges Novartis Gleevec Patent Infringement Suit a Sham
June 24, 2015: Class Action Alleges Novartis Gleevec Patent Infringement Suit a Sham
Complaint seeks permanent injunctive relief to prevent overcharges and damages, and bring generic Gleevec to market
See full article here: http://www.hbsslaw.com/newsroom/Class-Action-Alleges-Novartis-Gleevec-Patent-Infringement-Suit-a-Sham
Generics
A class of medicinal products where the drug is comparable to a branded product in dosage form, strength, route of administration, quality and efficacy, and intended use. A generic drug can only be marketed after patent exclusivity protection ends.
Gene
A unit of information present as DNA; a gene usually contains the blueprint for a protein.
CML
Chronic Myeloid Leukemia, also called Chronic Myelogenous Leukemia
A chronic disease of the blood and bone marrow that results from a transformation of a stem cell.
EU e-Privacy Directive
EU e-Privacy Directive
This website uses cookies to manage authentication, navigation, and other functions. By using our website, you agree that we can place these types of cookies on your device.
You have declined cookies. This decision can be reversed.
You have allowed cookies to be placed on your computer. This decision can be reversed.